These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 31408137)

  • 1. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.
    ; Nasrallah IM; Pajewski NM; Auchus AP; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Doshi J; Erus G; Fine LJ; Gaussoin SA; Harris D; Johnson KC; Kimmel PL; Kurella Tamura M; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB; Williamson JD; Bryan RN
    JAMA; 2019 Aug; 322(6):524-534. PubMed ID: 31408137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
    Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C; Williamson JD; Pajewski NM; Bryan RN;
    JAMA Neurol; 2021 May; 78(5):568-577. PubMed ID: 33683313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Rashid T; Li K; Toledo JB; Nasrallah I; Pajewski NM; Dolui S; Detre J; Wolk DA; Liu H; Heckbert SR; Bryan RN; Williamson J; Davatzikos C; Seshadri S; Launer LJ; Habes M
    JAMA Netw Open; 2023 Mar; 6(3):e231055. PubMed ID: 36857053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
    ; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
    JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
    Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
    JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.
    Williamson JD; Launer LJ; Bryan RN; Coker LH; Lazar RM; Gerstein HC; Murray AM; Sullivan MD; Horowitz KR; Ding J; Marcovina S; Lovato L; Lovato J; Margolis KL; Davatzikos C; Barzilay J; Ginsberg HN; Linz PE; Miller ME;
    JAMA Intern Med; 2014 Mar; 174(3):324-33. PubMed ID: 24493100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
    Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
    JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY).
    White WB; Wakefield DB; Moscufo N; Guttmann CRG; Kaplan RF; Bohannon RW; Fellows D; Hall CB; Wolfson L
    Circulation; 2019 Nov; 140(20):1626-1635. PubMed ID: 31607143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
    Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
    Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
    JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
    Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
    Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial.
    Croall ID; Tozer DJ; Moynihan B; Khan U; O'Brien JT; Morris RG; Cambridge VC; Barrick TR; Blamire AM; Ford GA; Markus HS;
    JAMA Neurol; 2018 Jun; 75(6):720-727. PubMed ID: 29507944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial.
    He J; Zhang Y; Xu T; Zhao Q; Wang D; Chen CS; Tong W; Liu C; Xu T; Ju Z; Peng Y; Peng H; Li Q; Geng D; Zhang J; Li D; Zhang F; Guo L; Sun Y; Wang X; Cui Y; Li Y; Ma D; Yang G; Gao Y; Yuan X; Bazzano LA; Chen J;
    JAMA; 2014 Feb; 311(5):479-89. PubMed ID: 24240777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT).
    Kern KC; Nasrallah IM; Bryan RN; Reboussin DM; Wright CB
    Neuroimage Clin; 2023; 40():103513. PubMed ID: 37774646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
    Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
    JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
    JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults.
    Williamson W; Lewandowski AJ; Forkert ND; Griffanti L; Okell TW; Betts J; Boardman H; Siepmann T; McKean D; Huckstep O; Francis JM; Neubauer S; Phellan R; Jenkinson M; Doherty A; Dawes H; Frangou E; Malamateniou C; Foster C; Leeson P
    JAMA; 2018 Aug; 320(7):665-673. PubMed ID: 30140877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.